How to study optimal timing of PET/CT for monitoring of cancer treatment
about
Positron emission tomography imaging of atherosclerosisAntibody-based imaging of HER-2: moving into the clinic.PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow.Positron Emission Tomography and Near-Infrared Fluorescence Imaging of Vascular Endothelial Growth Factor with Dual-Labeled Bevacizumab.Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody.FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.In vivo targeting and positron emission tomography imaging of tumor vasculature with (66)Ga-labeled nano-graphenePositron emission tomography imaging of tumor angiogenesis with a 66Ga-labeled monoclonal antibody.Graphene: a versatile nanoplatform for biomedical applications.ImmunoPET and near-infrared fluorescence imaging of CD105 expression using a monoclonal antibody dual-labeled with (89)Zr and IRDye 800CW.(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challengeIn a "nutshell": intrinsically radio-labeled quantum dots.Molecular imaging of insulin-like growth factor 1 receptor in cancer.Immuno-PET of tissue factor in pancreatic cancer.Tumor vasculature targeting and imaging in living mice with reduced graphene oxide.PET imaging of CD105/endoglin expression with a ⁶¹/⁶⁴Cu-labeled Fab antibody fragmentQuantum dot-based nanoprobes for in vivo targeted imaging.Multimodality imaging of CXCR4 in cancer: current status towards clinical translation.Biomedical applications of zinc oxide nanomaterials.Peptoid and Positron Emission Tomography: an Appealing CombinationA Review on Green Synthesis, Biomedical Applications, and Toxicity Studies of ZnO NPs
P2860
Q26824610-77C8538F-4687-43BB-920C-59B82AB0A3B9Q30423880-663E6334-8B93-47DB-8D20-BAB6EA5477CEQ34464099-7D938C96-BD91-402E-ACF9-D693A590BEF9Q35646547-7F64DD47-96FF-4E40-8384-A257BF9A2BACQ35809541-2140100B-3923-4719-8F4A-3AB383F4621FQ35828077-A05EEE30-03FF-4E9B-94CC-5119B53F4574Q35854802-0DFA62FC-6782-488B-A000-92AEC4AA62B4Q36034526-F6F849D0-B4F7-4FE4-958D-B1D0EE04C345Q36035392-0AC05D31-2A82-4C4E-9520-46E26FCE237BQ36185354-146FF3A6-7660-42B8-BCBC-A326647B71A5Q36337213-1CF91422-D29D-49D8-84C7-EC3433D0EE70Q36337263-4665E247-15A1-4235-8B15-BC1A2B16F052Q36337268-2C7C2760-CDD5-497E-8150-2176B6075B20Q36374066-1847A2CE-CEDE-4F7A-AACF-40A7214157F6Q36604948-7BB20550-42CB-4C04-83A5-18617BD16F9EQ36763112-EE440D60-BC98-48BD-A74D-F3A808E9F8C0Q37337213-E38700C7-D892-4070-B003-7245F47E1F22Q37337280-5E133544-1E81-42DB-AF38-F183624614D2Q37337342-B2A66E09-026C-4950-99EB-70BAEB9F8162Q38595230-2019F659-A613-465F-BF77-0FABC547F22BQ58805835-D514EF9A-3680-4CB2-85E3-BDE1C39D6364
P2860
How to study optimal timing of PET/CT for monitoring of cancer treatment
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
How to study optimal timing of PET/CT for monitoring of cancer treatment
@ast
How to study optimal timing of PET/CT for monitoring of cancer treatment
@en
type
label
How to study optimal timing of PET/CT for monitoring of cancer treatment
@ast
How to study optimal timing of PET/CT for monitoring of cancer treatment
@en
prefLabel
How to study optimal timing of PET/CT for monitoring of cancer treatment
@ast
How to study optimal timing of PET/CT for monitoring of cancer treatment
@en
P2093
P2860
P1476
How to study optimal timing of PET/CT for monitoring of cancer treatment
@en
P2093
Poul Flemming Høilund-Carlsen
Werner Vach
Wolfgang Weber
P2860
P577
2011-07-20T00:00:00Z